The year 2025 will be remembered in Armenia’s recent history as one of bold ambition, but also of exposed vulnerabilities.
BridgeBio's pipeline assets like encaleret and BBP-418 offer optionality but lack near-term cash flow and face regulatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results